Quality

How Is COFEPRIS Digitizing Medical Device Regulation?
Management & Regulatory How Is COFEPRIS Digitizing Medical Device Regulation?

This digital initiative addresses long-standing inefficiencies by providing a public mechanism to verify the legal status of medical devices sold throughout the country. For many years, the Mexican medical device market struggled with a lack of transparency, where paper-based records led to

How Is Global Pharmaceutical Quality Maintained at Scale?
Management & Regulatory How Is Global Pharmaceutical Quality Maintained at Scale?

Maintaining medicinal consistency across a global network requires navigating a labyrinth of geopolitical shifts and varying international regulatory expectations. The journey of a pharmaceutical product from a manufacturing plant to a patient’s local pharmacy is an intricate operation governed by

Is H5N1 in Fetal Bovine Serum a New Lab Biosafety Risk?
Biotech & Bioprocessing Is H5N1 in Fetal Bovine Serum a New Lab Biosafety Risk?

Laboratories specializing in virology and immunology must now evaluate if their current biosafety margins are sufficient to protect staff from aerosolized H5N1 exposure. The recent isolation of live, infectious H5N1 avian influenza from a commercial batch of fetal bovine serum (FBS) has sparked a

Can Seton Coastside Medical Center Overcome Its Challenges?
Management & Regulatory Can Seton Coastside Medical Center Overcome Its Challenges?

State officials and local supervisors are currently locked in a high-stakes standoff with the facility’s owners to ensure that critical acute care beds are not permanently lost. This situation has left the residents of Moss Beach and the surrounding Coastside area navigating a landscape of medical

Why Is Paying Cash Cheaper Than Using Your Health Insurance?
Management & Regulatory Why Is Paying Cash Cheaper Than Using Your Health Insurance?

When a hospital employee advised a patient to bypass her insurance provider, the cost of her procedure dropped by sixty percent, exposing deep systemic inefficiencies. This paradox is common in the healthcare landscape of 2026, where administrative complexity often inflates prices far beyond the

SCHOTT Pharma Sets New Science-Based Climate Targets
Management & Regulatory SCHOTT Pharma Sets New Science-Based Climate Targets

The move away from carbon offsetting signals a maturation in corporate sustainability where physical decarbonization takes precedence over accounting-based neutrality claims. This evolution reflects a growing understanding that the pharmaceutical industry must confront its environmental impact

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later